FI964212A7 - Röntgenvarjoainekoostumuksia, jotka sisältävät farmaseuttisesti hyväks yttäviä savia - Google Patents

Röntgenvarjoainekoostumuksia, jotka sisältävät farmaseuttisesti hyväks yttäviä savia Download PDF

Info

Publication number: FI964212A7
Authority: FI; Finland
Prior art keywords: pharmaceutically acceptable; compositions containing; contrast media; ray contrast; containing pharmaceutically
Prior art date: 1994-04-21

Application number

FI964212A

Other languages

English (en)

Swedish (sv)

Other versions

FI964212A0 (fi

FI964212L (fi

Inventor

Carl R Illig

Edward R Bacon

Eugene R Cooper

Gregory L Mcintire

John Toner

Tom Caulfield

Kimberly Estep

Stephen B Ruddy

Mary E Roberts

Brent D Douty

Original Assignee

Nycomed Imaging As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-04-21

Filing date

1995-03-16

Publication date

1996-10-18

1994-04-21 Priority claimed from US08/230,580 external-priority patent/US5476646A/en

1994-04-29 Priority claimed from US08/236,287 external-priority patent/US5424056A/en

1994-05-03 Priority claimed from US08/237,502 external-priority patent/US5492687A/en

1994-05-05 Priority claimed from US08/239,090 external-priority patent/US5484585A/en

1994-05-23 Priority claimed from US08/247,438 external-priority patent/US5531979A/en

1994-05-23 Priority claimed from US08/247,424 external-priority patent/US5360604A/en

1994-05-26 Priority claimed from US08/249,424 external-priority patent/US5472682A/en

1995-03-16 Application filed by Nycomed Imaging As filed Critical Nycomed Imaging As

1996-10-18 Publication of FI964212A7 publication Critical patent/FI964212A7/fi

1996-10-18 Publication of FI964212A0 publication Critical patent/FI964212A0/fi

1996-10-18 Publication of FI964212L publication Critical patent/FI964212L/fi

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
- A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
- A61K49/0461—Dispersions, colloids, emulsions or suspensions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
- A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
- A61K49/0495—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound intended for oral administration
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Nanotechnology (AREA)
Bioinformatics & Cheminformatics (AREA)
Biophysics (AREA)
Biotechnology (AREA)
General Engineering & Computer Science (AREA)
Medical Informatics (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Pharmacology & Pharmacy (AREA)
Crystallography & Structural Chemistry (AREA)
Dispersion Chemistry (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

FI964212A 1994-04-21 1995-03-16 Röntgenvarjoainekoostumuksia, jotka sisältävät farmaseuttisesti hyväksyttäviä savia FI964212L (fi)

Applications Claiming Priority (8)

Application Number	Priority Date	Filing Date	Title
US08/230,580 US5476646A (en)	1992-05-01	1994-04-21	X-ray contrast compositions containing iodophenoxyalkanes and pharmaceutically acceptable clays
US08/236,287 US5424056A (en)	1993-03-01	1994-04-29	X-ray contrast compositions containing iodoaniline derivatives and pharmaceutically acceptable clays
US08/237,502 US5492687A (en)	1993-03-11	1994-05-03	Compositions of iodophenoxy alkylene ethers and pharmaceutically acceptable clays for visualization of the gastrointestinal tract
US08/239,090 US5484585A (en)	1993-03-11	1994-05-05	Compositions of iodobenzoic acid derivatives and pharmaceutically acceptable clays for visualization of the gastrointestinal tract
US08/247,438 US5531979A (en)	1993-02-02	1994-05-23	Compositions of iodophenoxy alkanes and iodophenyl ethers and pharmaceutically acceptable clays for visualization of the gastrointestinal tract
US08/247,424 US5360604A (en)	1994-04-14	1994-05-23	X-ray contrast compositions containing an organic crystalline X-ray contrast agent in combination with pharmaceutically acceptable clays
US08/249,424 US5472682A (en)	1993-03-31	1994-05-26	Compositions of iodophenyl esters and iodophenyl sulfonates and pharmaceutically acceptable clays for visualization of the gastrointestinal tract
PCT/GB1995/000566 WO1995028969A1 (en)	1994-04-21	1995-03-16	X-ray contrast compositions containing pharmaceutically acceptable clays

Publications (3)

Publication Number	Publication Date
FI964212A7 true FI964212A7 (fi)	1996-10-18
FI964212A0 FI964212A0 (fi)	1996-10-18
FI964212L FI964212L (fi)	1996-10-18

Family

ID=27569393

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI964212A FI964212L (fi)	1994-04-21	1995-03-16	Röntgenvarjoainekoostumuksia, jotka sisältävät farmaseuttisesti hyväksyttäviä savia

Country Status (9)

Country	Link
EP (1)	EP0756497A1 (fi)
JP (1)	JPH09512029A (fi)
CN (1)	CN1147206A (fi)
AU (1)	AU1897795A (fi)
CA (1)	CA2187019A1 (fi)
FI (1)	FI964212L (fi)
HU (1)	HUT76304A (fi)
NO (1)	NO964451L (fi)
WO (1)	WO1995028969A1 (fi)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5466440A (en) *	1994-12-30	1995-11-14	Eastman Kodak Company	Formulations of oral gastrointestinal diagnostic X-ray contrast agents in combination with pharmaceutically acceptable clays
JP4670229B2 (ja) *	2003-06-10	2011-04-13	味の素株式会社	Ｃｔコロノグラフィにおける消化管造影用組成物
AU2005214167B2 (en)	2004-02-13	2008-08-07	Warner-Lambert Company Llc	Androgen receptor modulators
CA2563291A1 (en)	2004-04-13	2005-10-27	Warner-Lambert Company Llc	4-cyano-phenoxy-alkyl carboxyl derivatives as androgen modulators
EP1740533A1 (en)	2004-04-22	2007-01-10	Warner-Lambert Company LLC	Androgen modulators
BRPI0513020A (pt)	2004-07-08	2008-04-22	Warner Lambert Co	moduladores de andrÈgenio, seus usos, composição farmacêutica, formulação farmacêutica tópica e artigo de fabricação
CN1330380C (zh) *	2005-03-18	2007-08-08	山东师范大学	一种x－射线造影剂组合物
TW200724139A (en)	2005-05-05	2007-07-01	Warner Lambert Co	Androgen modulators
EP2968619B1 (en)	2013-03-15	2021-08-11	The Regents of the University of California	Enteric ct contrast material based on low-z atoms
EP3033012A4 (en)	2013-08-16	2017-04-19	The Regents of the University of California	Silicone-based enteric ct contrast material
CN106075476B (zh) *	2016-07-30	2019-05-31	温州市人民医院	一种造影剂

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB767788A (en) *	1953-12-28	1957-02-06	Schering Corp	Polyiodinated phenyl fatty acid compounds and process for their manufacture
CH338274A (fr) *	1954-01-08	1959-05-15	Schering Corp	Utilisation comme agents radio-opaques de phénoxy-acides gras polyiodés
CA985626A (en) *	1970-03-10	1976-03-16	E.R. Squibb And Sons	Coating composition for moist surface
US5260049A (en) *	1992-05-01	1993-11-09	Sterling Winthrop Inc.	X-ray contrast compositions comprising alkoxyphenols
CA2094893A1 (en) *	1992-05-01	1993-11-02	Carl R. Illig	X-ray contrast compositions containing film-forming materials
NZ250063A (en) *	1992-12-14	1996-03-26	Eastman Kodak Co	Iodinated aromatic acid ester derivatives; x-ray contrast compositions
US5322679A (en) *	1992-12-16	1994-06-21	Sterling Winthrop Inc.	Iodinated aroyloxy esters
US5316755A (en) *	1993-02-02	1994-05-31	Sterling Winthrop Inc.	Compositions of iodophenoxy alkanes and iodophenyl ethers for visualization of the gastrointestinal tract
US5326553A (en) *	1993-02-02	1994-07-05	Sterling Winthrop Inc.	Compositions of iodophenoxy alkanes and iodophenyl ethers in film-forming materials for visualization of the gastrointestinal tract
US5308607A (en) *	1993-02-04	1994-05-03	Sterling Winthrop Inc.	Compositions of alkylbenzenes for visualization of the gastrointestinal tract using X-ray contrast
US5334370A (en) *	1993-02-04	1994-08-02	Sterling Winthrop Inc.	Compositions of alkylbenzenes in film-forming materials for visualization of the gastrointestinal tract
US5310537A (en) *	1993-03-01	1994-05-10	Sterling Winthrop Inc.	Compositions of iodoaniline derivatives for visualization of the gastrointestinal tract
US5310538A (en) *	1993-03-11	1994-05-10	Sterling Winthrop Inc.	Compositions of iodophenoxy alkylene ethers in film-forming materials for visualization of the gastrointestinal tract
US5312616A (en) *	1993-03-11	1994-05-17	Sterling Winthrop Inc.	Compositions of iodobenzoic acid derivatives in film-forming materials for visualization of the gastrointestinal tract
US5344638A (en) *	1993-03-11	1994-09-06	Sterling Winthrop Inc.	Compositions of iodobenzoic acid derivatives for visualization of the gastrointestinal tract
US5318769A (en) *	1993-03-31	1994-06-07	Sterling Winthrop Inc.	Compositions of iodophenyl esters for X-ray visualization of the gastrointestinal tract
US5336484A (en) *	1993-03-31	1994-08-09	Sterling Winthrop Inc.	Compositions of iodophenyl esters and iodophenyl sulfonates in film-forming materials for visualization of the gastronintestinal tract
US5360604A (en) *	1994-04-14	1994-11-01	Sterling Winthrop Inc.	X-ray contrast compositions containing an organic crystalline X-ray contrast agent in combination with pharmaceutically acceptable clays

1995
- 1995-03-16 FI FI964212A patent/FI964212L/fi not_active Application Discontinuation
- 1995-03-16 AU AU18977/95A patent/AU1897795A/en not_active Abandoned
- 1995-03-16 JP JP7527425A patent/JPH09512029A/ja active Pending
- 1995-03-16 CN CN95192622A patent/CN1147206A/zh active Pending
- 1995-03-16 WO PCT/GB1995/000566 patent/WO1995028969A1/en not_active Ceased
- 1995-03-16 CA CA002187019A patent/CA2187019A1/en not_active Abandoned
- 1995-03-16 EP EP95911399A patent/EP0756497A1/en not_active Withdrawn
- 1995-03-16 HU HU9602908A patent/HUT76304A/hu unknown
1996
- 1996-10-18 NO NO964451A patent/NO964451L/no unknown

Also Published As

Publication number	Publication date
NO964451L (no)	1996-12-18
HU9602908D0 (en)	1996-12-30
JPH09512029A (ja)	1997-12-02
WO1995028969A1 (en)	1995-11-02
MX9604899A (es)	1998-03-31
CN1147206A (zh)	1997-04-09
AU1897795A (en)	1995-11-16
HUT76304A (en)	1997-07-28
NO964451D0 (no)	1996-10-18
FI964212A0 (fi)	1996-10-18
EP0756497A1 (en)	1997-02-05
CA2187019A1 (en)	1995-11-02
FI964212L (fi)	1996-10-18

Publication	Publication Date	Title
FI970995L (fi)	1997-04-25	Farmaseuttisia yhdisteitä
FI971018L (fi)	1997-04-18	Farmaseuttisia yhdisteitä
TR199501447A2 (tr)	1996-06-21	Oral bilesimler.
BR9508844A (pt)	1999-05-04	Composição oral
GB9402807D0 (en)	1994-04-06	Pharmaceutical compounds
BR9506536A (pt)	1997-09-16	Composição oral
GB9410387D0 (en)	1994-07-13	Pharmaceutical compounds
FI954243A7 (fi)	1996-03-13	Farmaseuttiset yhdisteet
NO972937D0 (no)	1997-06-23	Farmasöytiske piperazinforbindelser
GB2286394B (en)	1998-08-12	Pharmaceutical compounds
ID17561A (id)	1998-01-08	Komposisi untuk pemakaian luar
FI964212A7 (fi)	1996-10-18	Röntgenvarjoainekoostumuksia, jotka sisältävät farmaseuttisesti hyväks yttäviä savia
BR9507768A (pt)	1997-09-02	Composição farmacêutica
TR199501082A2 (tr)	1996-06-21	Farmasötik formülasyonlar.
ITMI942166A0 (it)	1994-10-21	Composizioni farmaceutiche miorilassanti
FI951872A7 (fi)	1996-04-18	Röntgenkuvauslaite
FI963299L (fi)	1996-08-23	Röntgenvarjoainekoostumukset, jotka sisältävät selluloosajohdannaisia
FI950423L (fi)	1995-08-02	Uusia 3-bentsoyyli-3,7-diatsibisyklo(3,3,1)nonaani-yhdisteitä sisältävät lääkeaineet
NO954695D0 (no)	1995-11-21	Jod-borforbindelser egnet som röntgenkontrastmidler, og farmasöytiske forbindelser derav
FI954050L (fi)	1996-03-02	Lääkekoostumuksia
FI962738L (fi)	1996-07-03	Farmaseuttiset koostumukset
GB9402805D0 (en)	1994-04-06	Pharmaceutical compounds
IT1272935B (it)	1997-07-01	Composizione farmaceutica contenente n-acetil-cisteina
KR960020598U (ko)	1996-07-18	로터리 척
NO962816D0 (no)	1996-07-03	Farmasöytiske forbindelser

Legal Events

Date	Code	Title	Description
1998-09-30	FD	Application lapsed